Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 3737 3768 3793 3798 3799
This examiner grants 68% of resolved cases
Angela Marie Hoffa works in Tech Center 3700 and Art Unit 3737. She has 563 resolved cases. Her allowance rate is 67.5 percent. This 67.5 percent rate suggests a generally positive environment for applicants seeking patent grants. The 563 resolved cases provide a reliable statistical baseline for her examination performance in this unit.
The interview lift is 28.4 percent. This 28.4 percent increase in the likelihood of allowance indicates that interviews have a significant positive impact on prosecution. Practitioners can use this 28.4 percent lift to resolve technical issues and move toward an allowance. This approach is supported by the 563 cases she has resolved.
The median time to allowance is 1498 days. This 1498 days duration is a key metric for managing the prosecution timeline. The combination of the 67.5 percent allowance rate and the 1498 days pendency indicates a predictable path to issuance. Practitioners can use these figures to plan their strategy in Art Unit 3737.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19543732 | IMPLANT STABILITY SENSOR SYSTEM AND METHOD | Non-Final OA | ORTHOIQ, INC. |
| 18523542 | INTEGRATION OF ROBOTIC ARMS WITH SURGICAL PROCEDURES | Non-Final OA | PROCEPT BioRobotics Corporation |
| 19060759 | ULTRASONIC ENDOSCOPE | Non-Final OA | FUJIFILM Corporation |
| 17727013 | SURGICAL ROBOT PLATFORM | Final Rejection | GLOBUS MEDICAL, INC. |
| 18211915 | AUTOMATIC PROBE REINSERTION | Final Rejection | Biosense Webster (Israel) Ltd. |
| 18608575 | TRACKING DEVICE AND METHOD OF USING THE SAME | Final Rejection | Medtronic Navigation, Inc. |
| 19085265 | METHODS TO TREAT LONG-COVID AND INFLUENZA | Non-Final OA | Tesla BioHealing, LLC |
| 18594188 | METHOD OF REGISTERING A PATIENT WITH MEDICAL INSTRUMENT NAVIGATION SYSTEM | Non-Final OA | Acclarent, Inc. |
| 18286618 | MRI BASED SYSTEM AND METHOD FOR DETECTING IRON-RELATED ENTITIES IN A REGION OF INTEREST | Final Rejection | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. |
| 18298306 | SYSTEMS AND METHODS FOR PROVIDING ALPHA BURST BRAIN STIMULATION | Non-Final OA | Wave Neuroscience, Inc. |
| 17120950 | TISSUE MARKERS | Final Rejection | BOSTON MEDICAL CENTER CORPORATION |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy